Canada markets close in 3 hours 56 minutes

Myriad Genetics, Inc. (MYGN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
24.65+0.69 (+2.90%)
As of 12:03PM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 2.17B
Enterprise Value 2.18B
Trailing P/E N/A
Forward P/E 2.50k
PEG Ratio (5 yr expected) 1.40
Price/Sales (ttm)2.63
Price/Book (mrq)2.77
Enterprise Value/Revenue 2.89
Enterprise Value/EBITDA -11.03

Trading Information

Stock Price History

Beta (5Y Monthly) 1.97
52-Week Change 336.39%
S&P500 52-Week Change 325.59%
52 Week High 325.18
52 Week Low 313.82
50-Day Moving Average 320.64
200-Day Moving Average 319.06

Share Statistics

Avg Vol (3 month) 3690.12k
Avg Vol (10 day) 31M
Shares Outstanding 590.48M
Implied Shares Outstanding 690.48M
Float 870.8M
% Held by Insiders 12.35%
% Held by Institutions 1102.93%
Shares Short (Apr 15, 2024) 45.5M
Short Ratio (Apr 15, 2024) 48.51
Short % of Float (Apr 15, 2024) 48.52%
Short % of Shares Outstanding (Apr 15, 2024) 46.08%
Shares Short (prior month Mar 15, 2024) 44.8M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 22:1
Last Split Date 3Mar 26, 2009

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin -30.30%
Operating Margin (ttm)-13.65%

Management Effectiveness

Return on Assets (ttm)-6.27%
Return on Equity (ttm)-29.41%

Income Statement

Revenue (ttm)774.2M
Revenue Per Share (ttm)9.11
Quarterly Revenue Growth (yoy)11.60%
Gross Profit (ttm)N/A
EBITDA -61.8M
Net Income Avi to Common (ttm)-234.6M
Diluted EPS (ttm)-3.18
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)104.3M
Total Cash Per Share (mrq)1.15
Total Debt (mrq)146.8M
Total Debt/Equity (mrq)19.32%
Current Ratio (mrq)1.99
Book Value Per Share (mrq)8.40

Cash Flow Statement

Operating Cash Flow (ttm)-96.3M
Levered Free Cash Flow (ttm)-32.95M